Skip to main content

Table 4 Analyses of 19 patients who had experienced IBTR

From: Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer

No. Age Histology of primary tumor Subtype RM RT Interval to IBTR (months) Histology of IBTR 2nd recurrence Interval to 2nd recurrences (mo.) F/U duration (months) Overall survival (months)
1 60 DCIS ER + Neg. Not done 12 DCIS none N/A 41 80
2 26 DCIS ER - Pos. Done 13 DCIS none N/A 126 128
3 52 DCIS ER + Pos. Done 14 IDC none N/A 26 30
4 56 DCIS ER - Neg. Not done 20 IDC none N/A 42 114
5 43 DCIS ER - Neg. Done 47 IDC none N/A 52 52
6 31 Metaplastic TN Neg. Done 14 Metaplastic, TN none N/A 30 30
7 45 IDC TN Neg. Done 8 IDC, TN lung 6 18 18 (dead)
8 48 IDC TN Neg. Not done 14 IDC, TN   N/A 49 74
9 44 IDC TN Neg. Done 15 IDC, TN   N/A 34 34
10 49 IDC TN Neg. Done 16 IDC, TN lung 9 35 35 (dead)
11 33 IDC HER2 Neg. Done 17 IDC, TN   N/A 62 69
12 36 IDC Luminal Neg. Done 21 IDC, Luminal bone 10 36 36
13 41 IDC TN Neg. Done 22 IDC, HER-2 lung 15 38 42
14 65 IDC Luminal Neg. Not done 30 IDC, Luminal   N/A 36 36
15 43 IDC Luminal Pos. Not done 30 IDC, Luminal   N/A 38 47
16 44 IDC TN Neg. Done 34 IDC, TN   N/A 52 52
17 51 IDC Luminal Neg. Done 39 IDC, Luminal   N/A 49 60
18 48 IDC TN Neg. Done 47 IDC, TN   N/A 63 77
19 39 IDC HER2 Neg. Done 52 IDC, HER2 lung 5 78 78 (dead)
  1. Neg. negative, Pos. positive, TN triple negative